Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: Toward more specific ligands

被引:22
作者
Filipponi, E
Cecchetti, V
Tabarrini, O
Bonelli, D
Fravolini, A
机构
[1] Univ Perugia, Ist Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Univ Perugia, Dipartimento Chim, I-06123 Perugia, Italy
关键词
cyclooxygenase-2; GRID characterization; principal component analysis (PCA); selectivity;
D O I
10.1023/A:1008180108753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery that proinflammatory prostaglandins are produced by cyclooxygenase-2 (COX-2), an inducible isoform of the constitutive cyclooxygenase-1 (COX-1), opened a new frontier in the treatment of inflammatory diseases, because the selective inhibition of COX-2 can lead to therapeutically effective compounds which do not have the common side effects of classical non-steroidal antiinflammatory drugs (NSAIDs). Different crystallographic structures of both free COX-1 and COX-2 as well as complexes with inhibitors have been solved. Because of the great similarity between the two enzymes, it is difficult to detect the most important structural and physicochemical features that would be useful for designing inhibitors with an improved selectivity. In this paper we describe the application of a chemometric procedure to the study of COX-2 selective inhibition. This method, developed to reveal the most suitable regions of isoenzymes for the design of selective ligands, also has a very practical utility. GRID multivariate characterization of the enzymes and subsequent Principal Component Analysis (PCA) of the descriptor variables allow the identification of chemical groups that could be added to a core template structure to increase ligand selectivity.
引用
收藏
页码:277 / 291
页数:15
相关论文
共 32 条
[1]  
BARONI M, 1998, GOLPE V 4 0 2
[2]   PREDICTIVE ABILITY OF REGRESSION-MODELS .1. STANDARD-DEVIATION OF PREDICTION ERRORS (SDEP) [J].
CRUCIANI, G ;
BARONI, M ;
CLEMENTI, S ;
COSTANTINO, G ;
RIGANELLI, D ;
SKAGERBERG, B .
JOURNAL OF CHEMOMETRICS, 1992, 6 (06) :335-346
[3]   A SEARCH FOR SPECIFICITY IN DNA-DRUG INTERACTIONS [J].
CRUCIANI, G ;
GOODFORD, PJ .
JOURNAL OF MOLECULAR GRAPHICS, 1994, 12 (02) :116-129
[4]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[5]  
GANS KR, 1990, J PHARMACOL EXP THER, V254, P180
[6]   A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors [J].
Gierse, JK ;
McDonald, JJ ;
Hauser, SD ;
Rangwala, SH ;
Koboldt, CM ;
Seibert, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15810-15814
[8]   DETECTION OF INDUCIBLE PROSTAGLANDIN-H SYNTHASE-2 IN CELLS IN THE EXUDATE OF RAT CARRAGEENAN-INDUCED PLEURISY [J].
HARADA, Y ;
HATANAKA, K ;
SAITO, M ;
MAJIMA, M ;
OGINO, M ;
KAWAMURA, M ;
OHNO, T ;
YANG, QS ;
KATORI, M ;
YAMAMOTO, S .
BIOMEDICAL RESEARCH-TOKYO, 1994, 15 (02) :127-130
[9]   HUMAN CYCLOOXYGENASE-2 CDNA [J].
HLA, T ;
NEILSON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388
[10]   Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [J].
Kurumbail, RG ;
Stevens, AM ;
Gierse, JK ;
McDonald, JJ ;
Stegeman, RA ;
Pak, JY ;
Gildehaus, D ;
Miyashiro, JM ;
Penning, TD ;
Seibert, K ;
Isakson, PC ;
Stallings, WC .
NATURE, 1996, 384 (6610) :644-648